Prescribing practices of inhaled corticosteroids for premature infants in the neonatal intensive care unit.
Prescribing practices of inhaled corticosteroids for premature infants in the neonatal intensive care unit.
复制标题
新生儿重症监护室早产儿吸入皮质类固醇的处方实践。
DOI:
10.1038/s41372-024-01891-w
复制
发表时间:
2024
期刊:
影响因子:
--
通讯作者:
Lang,JasonE
中科院分区:
文献类型:
--
作者:
Tang,Monica;Ibrahim,Anna;Laughon,Christopher;Moore,Kaila;Tejada,Angibel;Tran,Dean;Kilpatrick,Ryan;Greenberg,RachelG;Hornik,ChristophP;Zimmerman,Kanecia;Laughon,MatthewM;Clark,ReeseH;Lang,JasonE
ObjectiveDespite limited safety and efficacy data, inhaled corticosteroids (ICS) are prescribed to premature infants in the neonatal intensive care unit (NICU). We examined contemporary use and risk factors for ICS use in the NICU.Study designInfants <33 weeks gestational age and <1500 gm birth weight discharged from Pediatrix Medical Group NICUs between 2010 and 2020 were included. We evaluated the association between ICS prescription and clinical characteristics using univariable and multivariable logistic regression.ResultsOf 74,123 infants from 308 NICUs, 9253 (12.5%) were prescribed ICS: budesonide, fluticasone, or beclomethasone. Diagnosis of bronchopulmonary dysplasia (BPD), earlier gestational age, male sex, longer mechanical ventilation, oxygen support, and systemic steroids were independent risk factors for ICS prescription.ConclusionsUse of ICS is common in many NICUs and is associated with a diagnosis of BPD and healthcare utilization. Prospective trials are needed to establish the safety, efficacy, and optimal indication in this vulnerable population.
影响因子:
1.9
作者:
Zysman-Colman, Zofia;Tremblay, Genevieve M.;Landry, Jennifer S.
通讯作者:
Landry, Jennifer S.
影响因子:
2.5
作者:
Christoph Maas;Christian F. Poets;Dirk Bassler
通讯作者:
Dirk Bassler
影响因子:
3.6
作者:
O. Williams;A. Greenough
通讯作者:
A. Greenough